FUCHS SE NA ST O.N./ DE000A3E5D56 /
| 2024-04-26 9:41:18 PM | Chg. +0.4000 | Volume | Bid9:41:20 PM | Ask9:41:20 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 35.0000EUR | +1.16% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 5.28 bill.EUR | 3.13% | 16.88 |
GlobeNewswire
04-10
BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Rese...
GlobeNewswire
03-19
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full...
GlobeNewswire
03-12
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive...
GlobeNewswire
03-07
American Institutes for Research Education Experts to Present at the Council for Exceptional Childre...
GlobeNewswire
01-30
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...
GlobeNewswire
01-24
Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host...
GlobeNewswire
2023-12-09
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
2023-11-13
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portf...
GlobeNewswire
2023-11-06
Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...
GlobeNewswire
2023-10-19
CIO Leadership: The Visionary Leadership Needed to Drive an Enterprise Generative AI Strategy will P...
GlobeNewswire
2023-09-25
L.B. Foster and FUCHS Extend Strategic Partnership with Industry-Leading Friction Management Product...
GlobeNewswire
2023-09-06
OTC Markets Group Announces Expanded Relationship with Moomoo Financial Inc.
